We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Monitoring Cancer and Drug Delivery with Nanoparticles

By MedImaging International staff writers
Posted on 09 Dec 2014
Print article
A new type of nanoparticle has been developed that can be used to perform fluorescent imaging and MRI simultaneously to help track specific molecules and targeted drug delivery, and monitor the environment around a tumor.

The researchers used the nanoparticles in mice to track the movement and concentration of vitamin C by comparing the fluorescence and MRI contrast of the nanoparticles at different locations. The nanoparticles were assembled from separate polymer chains carrying either a nitroxide organic MRI contrast agent, or the fluorescent molecule Cy5.5. The chains were combined in a ratio of 99% nitroxides and 1% Cy5.5. Normally, the lifetime of the nitroxide is too short to obtain useful MRI images but was extended by the researchers by attaching the nitroxide to branched bottlebrush polymers architectures. Using this technique the researchers created nanoparticles carrying three different drugs and also the fluorescent agent.

According to Jeremiah A. Johnson, assistant professor of Chemistry at MIT and senior author of the study, "Someday you might be able to inject this into a patient and obtain real-time biochemical information about disease sites and also healthy tissues." The research was carried out at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) by a team of researchers and was published in the November 18, 2014, issue of Nature Communications.

Related Links:

MIT


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Compact C-Arm
Arcovis DRF-C S21
New
X-Ray QA Meter
Piranha CT
New
Color Doppler Ultrasound System
KC20

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more